Xylem (XYL) Expected to Announce Quarterly Earnings on Tuesday

Xylem (NYSE:XYL) is projected to post its Q2 2026 results before the market opens on Tuesday, July 28th. Analysts expect Xylem to announce earnings of $1.34 per share and revenue of $2.3444 billion for the quarter. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Parties may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Tuesday, July 28, 2026 at 9:00 AM ET.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The business had revenue of $2.12 billion for the quarter, compared to analysts’ expectations of $2.11 billion. During the same period in the previous year, the firm earned $1.03 EPS. The business’s quarterly revenue was up 2.7% on a year-over-year basis. On average, analysts expect Xylem to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Xylem Stock Down 1.6%

Shares of Xylem stock opened at $120.82 on Tuesday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. Xylem has a 52-week low of $105.29 and a 52-week high of $154.27. The stock has a market capitalization of $28.72 billion, a price-to-earnings ratio of 30.05, a P/E/G ratio of 1.75 and a beta of 1.03. The company’s 50 day moving average price is $113.40 and its 200-day moving average price is $123.26.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were issued a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s dividend payout ratio (DPR) is 42.79%.

Wall Street Analysts Forecast Growth

XYL has been the subject of several recent analyst reports. Barclays lowered their price objective on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research note on Wednesday, April 29th. Jefferies Financial Group raised Xylem from a “hold” rating to a “buy” rating and upped their price target for the company from $130.00 to $140.00 in a research report on Thursday, June 25th. CLSA upgraded Xylem to a “hold” rating in a report on Thursday, June 25th. UBS Group lifted their price objective on Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Finally, Oppenheimer reduced their target price on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $153.15.

Insider Activity at Xylem

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jerome A. Peribere purchased 1,210 shares of Xylem stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the purchase, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.32% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of XYL. Wexford Capital LP purchased a new position in Xylem during the 3rd quarter valued at about $27,000. FWL Investment Management LLC bought a new position in shares of Xylem during the second quarter valued at approximately $43,000. DV Equities LLC bought a new position in shares of Xylem during the fourth quarter valued at approximately $46,000. Johnson Financial Group Inc. purchased a new position in shares of Xylem during the third quarter valued at approximately $77,000. Finally, Zions Bancorporation National Association UT lifted its holdings in shares of Xylem by 36.1% during the fourth quarter. Zions Bancorporation National Association UT now owns 679 shares of the industrial products company’s stock valued at $92,000 after purchasing an additional 180 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.